Tag Archives: Irbesartan

Motion Seeks To Add Irbesartan and Losartan Lawsuits to Pending Valsartan Litigation

September 19, 2019 By: Austin Kirk
Cancer Risk from Valsartan, Losartan, Other Recalled Blood Pressure Drugs Still Being Investigated by FDA

August 29, 2019 By: Irvin Jackson
Valsartan Recalls May Have Been Caused By Indian Solvent Recovery Firm, At Least In Part: FDA

August 16, 2019 By: Irvin Jackson
Valsartan Recalls Resulted in Increase In Reports of Cancer Among Former Users: Report

July 15, 2019 By: Irvin Jackson
Core Discovery Underway in Lawsuits Over Valsartan Contamination

April 30, 2019 By: Irvin Jackson
FDA Releases List of 40 Hypertension Drugs That Do Not Contain Potentially Cancer-Causing Impurities

April 05, 2019 By: Irvin Jackson
More Irbesartan Tablet Recalls Issued Over NDEA Contamination

January 21, 2019 By: Irvin Jackson
Irbesartan Class Action Lawsuit Filed Over Recalled Blood Pressure Drug Tainted With Cancer-Causing Impurities

December 13, 2018 By: Irvin Jackson
Chinese Plant Linked To Valsartan Recalls Gets Warning Letter Over Manufacturing Problems

December 12, 2018 By: Irvin Jackson
Generic Avapro (Irbesartan) Recall Issued Over Cancer Risks From Manufacturing Impurities

October 31, 2018 By: Irvin Jackson

MDL Judge Schedules Ozempic Lawsuit Status Conferences Throughout 2025 (Posted 4 days ago)

With the first Ozempic lawsuit bellwether trials not expected to begin until at least late 2026 or early 2027, the court will address motions to dismiss and other “cross cutting” issues in 2025.

Valsartan Bellwether Lawsuit Over Cancer Caused by Recalled Blood Pressure Drug Set for September 8, 2025 (Posted 5 days ago)

The first Valsartan bellwether trial will begin on September 8, 2025, involving allegations that the generic hypertension drug contained toxic chemicals that resulted in a liver cancer diagnosis.

Bard PowerPort Lawyers Will Update Judge on Status of Litigation at Case Management Conference (Posted 6 days ago)

The judge presiding over all federal Bard PowerPort lawsuits will meet with lawyers today to review the status of pretrial proceedings and the selection of the next round of bellwether cases.

Tag Archives: Irbesartan

Motion Seeks To Add Irbesartan and Losartan Lawsuits to Pending Valsartan Litigation

Cancer Risk from Valsartan, Losartan, Other Recalled Blood Pressure Drugs Still Being Investigated by FDA

Valsartan Recalls May Have Been Caused By Indian Solvent Recovery Firm, At Least In Part: FDA

Valsartan Recalls Resulted in Increase In Reports of Cancer Among Former Users: Report

Core Discovery Underway in Lawsuits Over Valsartan Contamination

FDA Releases List of 40 Hypertension Drugs That Do Not Contain Potentially Cancer-Causing Impurities

More Irbesartan Tablet Recalls Issued Over NDEA Contamination

Irbesartan Class Action Lawsuit Filed Over Recalled Blood Pressure Drug Tainted With Cancer-Causing Impurities

Chinese Plant Linked To Valsartan Recalls Gets Warning Letter Over Manufacturing Problems

Generic Avapro (Irbesartan) Recall Issued Over Cancer Risks From Manufacturing Impurities

More Top Stories

Review A Case